IBO
Impact BioMedical Inc.
AMEXHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Frank D. Heuszel
IPO Date
2024-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Impact BioMedical Inc.
CEO
Frank D. Heuszel
IPO Date
2024-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
| 43,400 |
| $0.56 |
| 25 Mar 2026 | Grady Jason | director | S-Sale | Disposed | 50,000 | $0.65 |
| 6 Jan 2026 | DSS, INC. | 10 percent owner | S-Sale | Disposed | 115,600 | $0.55 |
| 6 Jan 2026 | DSS, INC. | 10 percent owner | S-Sale | Disposed | 45,400 | $0.54 |
| 27 May 2025 | DSS, INC. | 10 percent owner | S-Sale | Disposed | 115,600 | $0.55 |
| 27 May 2025 | DSS, INC. | 10 percent owner | S-Sale | Disposed | 45,400 | $0.54 |
| 7 Apr 2025 | DSS, INC. | 10 percent owner | S-Sale | Disposed | 890,800 | $0.95 |
| 7 Apr 2025 | Chan Heng Fai Ambrose | director | S-Sale | Disposed | 351,555 | $0.49 |
| 4 Apr 2025 | Chan Heng Fai Ambrose | director, 10 percent owner: | S-Sale | Disposed | 300,000 | $0.58 |